Arkolith/Insider Trading/CYT/Form 4

Renschler Markus MD

President and CEO, DirectorCyteir Therapeutics, Inc. (CYT) · full profile →Form 4 · filed Nov 22, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 20, 2023Option exercise(M)57K$1.69$96K1.0M
Nov 20, 2023Option exercise(M)28K$1.20$33K1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 20, 2023Option exercise(M)57K—$0246K
Nov 20, 2023Option exercise(M)28K—$05K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-056426) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML